Phillip Hunt

Director, Cardiovascular Metabolic Epidemiology
AstraZeneca Pharmaceuticals
Columbia, South Carolina, United States

Presentation(s):

• PB0549 - Healthcare Resource Use Among US Veterans Treated With Andexanet Alfa or 4-factor Prothrombin Complex Concentrate for Factor Xa Inhibitor-related Major Bleeding

  Monday, June 26, 2023
  18:30 – 19:30 ET